TNSN03154A1 - Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux. - Google Patents

Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux.

Info

Publication number
TNSN03154A1
TNSN03154A1 TNPCT/IB2002/002514A TNSN03154A TNSN03154A1 TN SN03154 A1 TNSN03154 A1 TN SN03154A1 TN SN03154 A TNSN03154 A TN SN03154A TN SN03154 A1 TNSN03154 A1 TN SN03154A1
Authority
TN
Tunisia
Prior art keywords
vaccine
mycoplasma bovis
methods
vaccines
animals
Prior art date
Application number
TNPCT/IB2002/002514A
Other languages
English (en)
Inventor
Robin Lee Keich
David Ross Mcgavin
Robert John Yancey
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN03154A1 publication Critical patent/TNSN03154A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENTION CONCERNE DES VACCINS A MYCOPLASMA BOVIS ET DES METHODES POUR LE TRAITEMENT OU LA PREVENTION D'UNE MALADIE OU AFFECTION CHEZ UN ANIMAL PROVOQUEE PAR UNE INFECTION PAR MYCOPLASMA BOVIS EN ADMINISTRANT A L'ANIMAL UNE QUANTITE EFFICACE D'UN VACCIN A MYCOPLASMA BOVIS. LE VACCIN A MYCOPLASMA BOVIS PEUT ETRE UNE PREPARATION VIVANTE, INACTIVEE OU MODIFIEE, DE CELLULES ENTIERES OU PARTIELLES, UN VACCIN A SOUS-UNITE, OU UN VACCIN A ACIDE NUCLEIQUE OU VACCIN A ADN. LE VACCIN A MYCOPLASMA BOVIS ADMINISTRE CONFORMEMENT A LA PRESENTE INVENTION PEUT ETRE SYNTHETISE OU PRODUIT PAR RECOMBINAISON. LA PRESENTE INVENTION CONCERNE EGALEMENT DES VACCINS MIXTES, DES PROCEDES POUR LA PREPARATION DE VACCINS A MYCOPLASMA BOVIS ET DES KITS.
TNPCT/IB2002/002514A 2001-07-02 2002-06-27 Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux. TNSN03154A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
TNSN03154A1 true TNSN03154A1 (fr) 2005-12-23

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
TNPCT/IB2002/002514A TNSN03154A1 (fr) 2001-07-02 2002-06-27 Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux.

Country Status (31)

Country Link
US (1) US20030147914A1 (fr)
EP (1) EP1401488A1 (fr)
JP (1) JP2004536106A (fr)
KR (1) KR20040030783A (fr)
CN (1) CN1522152A (fr)
AP (1) AP2002002568A0 (fr)
AR (1) AR036125A1 (fr)
BG (1) BG108496A (fr)
BR (1) BR0210798A (fr)
CA (1) CA2452580A1 (fr)
CZ (1) CZ20033465A3 (fr)
EA (1) EA200301324A1 (fr)
GT (1) GT200200139A (fr)
HN (1) HN2002000162A (fr)
HR (1) HRP20031078A2 (fr)
HU (1) HUP0501188A2 (fr)
IL (1) IL159516A0 (fr)
IS (1) IS7078A (fr)
MA (1) MA27048A1 (fr)
MX (1) MXPA03011815A (fr)
NO (1) NO20035767L (fr)
OA (1) OA12640A (fr)
PA (1) PA8549801A1 (fr)
PE (1) PE20030239A1 (fr)
PL (1) PL373891A1 (fr)
SK (1) SK15802003A3 (fr)
TN (1) TNSN03154A1 (fr)
UY (1) UY27365A1 (fr)
WO (1) WO2003004052A1 (fr)
YU (1) YU102103A (fr)
ZA (1) ZA200309747B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
WO2008030619A2 (fr) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Génotypage à base de pcr
ES2432392T3 (es) 2006-09-11 2013-12-03 Zoetis P Llc Bacterinas tratadas térmicamente y vacunas en emulsión preparadas a partir de tales bacterinas tratadas térmicamente
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CA2729080C (fr) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Vaccins pour le betail
EP2362780B1 (fr) * 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Utilisation de divers antigènes y compris des antigènes provenant de mycoplasma bovis dans une composition de vaccin multivalente
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
US9539209B2 (en) 2009-06-04 2017-01-10 National Institute Of Infectious Diseases Vaccine for mycoplasma infection
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
WO2014105672A1 (fr) 2012-12-28 2014-07-03 Boehringer Ingelheim Vetmedica Gmbh Procédé de fabrication d'un vaccin de mycoplasme
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
BR0015398A (pt) * 1999-11-08 2002-06-25 Biomune Vacinas para mycoplasma bovis e processos de uso
DE29921392U1 (de) * 1999-12-06 2000-03-16 Felgentraeger & Co Oeko Chem U Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
PA8549801A1 (es) 2003-09-17
BG108496A (en) 2005-02-28
OA12640A (en) 2006-06-15
YU102103A (sh) 2006-05-25
CZ20033465A3 (cs) 2004-12-15
MXPA03011815A (es) 2004-04-02
BR0210798A (pt) 2006-05-23
EP1401488A1 (fr) 2004-03-31
CN1522152A (zh) 2004-08-18
PE20030239A1 (es) 2003-03-21
MA27048A1 (fr) 2004-12-20
AP2002002568A0 (en) 2002-06-30
UY27365A1 (es) 2003-04-30
PL373891A1 (en) 2005-09-19
HN2002000162A (es) 2002-09-17
WO2003004052A1 (fr) 2003-01-16
KR20040030783A (ko) 2004-04-09
US20030147914A1 (en) 2003-08-07
HRP20031078A2 (en) 2005-08-31
GT200200139A (es) 2003-02-13
IS7078A (is) 2003-12-15
CA2452580A1 (fr) 2003-01-16
NO20035767L (no) 2004-01-30
EA200301324A1 (ru) 2004-12-30
HUP0501188A2 (en) 2006-05-29
ZA200309747B (en) 2005-05-27
SK15802003A3 (sk) 2005-01-03
AR036125A1 (es) 2004-08-11
JP2004536106A (ja) 2004-12-02
IL159516A0 (en) 2004-06-01

Similar Documents

Publication Publication Date Title
TNSN03154A1 (fr) Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux.
TNSN03155A1 (fr) Vaccination unidose avec mycoplasma hyopneumoniae
JP2005534752A5 (fr)
CN102449170A (zh) 寡核苷酸功能化的纳米颗粒的递送
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
MA30252B1 (fr) Vaccin therapeutique
Tang et al. Engineered Bdellovibrio bacteriovorus: A countermeasure for biofilm-induced periodontitis
MA27699A1 (fr) Vaccin contre vhc
Vilares et al. Isolation and molecular characterization of Toxoplasma gondii isolated from pigeons and stray cats in Lisbon, Portugal
ES2285698T3 (es) Procedimiento para la preparacion de un pienso para cerdas.
RU2433485C1 (ru) Способ экспериментального моделирования пародонтита
FR2507479A1 (fr) Vaccin contre les infections chlamydiennes des animaux d'elevage
RU2195938C1 (ru) Способ получения регидратационного средства "регидратон свф"
RU2812192C1 (ru) Способ профилактики родовых и послеродовых осложнений коров
JP2004210769A (ja) 魚類冷水病ワクチン
RU2787754C1 (ru) Способ лечения маститов крупного рогатого скота
RU2093177C1 (ru) Препарат "дина" для лечения и профилактики заболеваний млекопитающих, птиц и рептилий
RU2709809C1 (ru) Способ повышения клеточного иммунитета лабораторных животных
RU2165757C1 (ru) Лечебно-профилактическое средство для молодняка сельскохозяйственных животных и птицы
Hong et al. Transmission modes of Pneumocystis carinii among rats observed by karyotype analysis
JP2001342141A (ja) 水棲動物・陸棲動物用薬剤及び飼料
RU2212246C2 (ru) Способ исследования терапевтических средств при моделировании криптоспоридиоза
Dua Absorption of magnesium, calcium, sodium, potassium, chloride and phosphate from the isolated reticulo-rumen and the effect of increasing the intraruminal potassium concentrations on the absorption of these electrolytes in sheep
Lawson et al. ERA strain rabies vaccine--intracerebral passage in dogs.
WO2004103408A2 (fr) Composition vaccinale comprenant du phosphate de fer a titre d’adjuvant vaccinal